The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement

Brachytherapy

Volumn 9, Issue 2, 2010, Pages 145-150

  Cheung, Arthur K ^a   Chen, Ming Hui ^b   Moran, Brian J ^c   Braccioforte, Michelle H ^c   Dosoretz, Daniel E ^d   Salenius, Sharon ^d   Katin, Michael ^d   Ross, Rudi ^d   D'Amico, Anthony V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Prostate Cancer Foundation of Chicago   (United States)

^d 21ST CENTURY ONCOLOGY   (United States)

Author keywords

Brachytherapy; External beam radiation therapy; Patterns of care; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER;

BRACHYTHERAPY; COHORT STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77949580240     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.08.001     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Cooperberg M.R., Lubeck D.P., Meng M.V., et al. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141-2149
3. Jacobsen S.J., Katusic S.K., Bergstralh E.J., et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 274 (1995) 1445-1449
4. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
5. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
6. Thompson I., Thrasher J.B., Aus G., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177 (2007) 2106-2131
7. Lee W.R., Moughan J., Owen J.B., et al. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: A comprehensive survey of prostate brachytherapy in the United States. Cancer 98 (2003) 1987-1994
8. Mettlin C.J., Murphy G.P., McDonald C.J., et al. The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 86 (1999) 1877-1882
9. Zietman A., Moughan J., Owen J., et al. The Patterns of Care Survey of radiation therapy in localized prostate cancer: Similarities between the practice nationally and in minority-rich areas. Int J Radiat Oncol Biol Phys 50 (2001) 75-80
10. Merrick G.S., Butler W.M., Wallner K.E., et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 61 (2005) 32-43
11. Blasko J.C., Grimm P.D., Sylsvester J.E., et al. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 57 (2000) 273-278
12. Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173 (2005) 1562-1566
13. Critz F.A., Williams W.H., Levinson A.K., et al. Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques. J Urol 164 (2000) 738-741 discussion 741-743
14. Zeitlin S.I., Sherman J., Raboy A., et al. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 160 (1998) 91-96
15. Merrick G.S., Butler W.M., Wallner K.E., et al. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 454-461
16. Merrick G.S., Butler W.M., Wallner K.E., et al. Late rectal function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 57 (2003) 42-48
17. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52 (2002) 893-902
18. Brandeis J.M., Litwin M.S., Burnison C.M., et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163 (2000) 851-857
19. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55 (2000) 736-742
20. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358 (2008) 1250-1261
21. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 789-799
22. Lee W.R., Sharkey J., Cowan J.E., et al. Prostate brachytherapy: A descriptive analysis from CaPSURE. Brachytherapy 6 (2007) 123-128
23. In: Agresti A. (Ed). Categorical data analysis. 2nd ed. (2002), John Wiley & Sons, New York, NY p. 70-114, 165-210
24. In: Hollander M., and Wolfe D.A. (Eds). Nonparametric statistical methods. 2nd ed. (1999), John Wiley & Sons, New York, NY 106-140
25. Akaike H. Information theory and an extension of the maximum likelihood principle, 1973 principle. In: Petrov B.N., and Csaki F. (Eds). International symposium on information theory (1973), Akademia Kiado, Budapest 267-281
26. Critz F.A. Summary of simultaneous irradiation for prostate cancer. Urology 64 (2004) 633-636
27. Brandeis J., Pashos C.L., Henning J.M., et al. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 89 (2000) 1792-1799
28. White V., Pruden M., Giles G., et al. The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 101 (2004) 476-485
29. Harlan L.C., Clegg L.X., and Trimble E.L. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 21 (2003) 3488-3494
30. Eifel P.J., Moughan J., Erickson B., et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: A patterns of care study. Int J Radiat Oncol Biol Phys 60 (2004) 1144-1153
31. Barbera L., Paszat L., Thomas G., et al. The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation. Int J Radiat Biol Phys 64 (2006) 1389-1394
32. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
33. Grol R., and Grimshaw J. From best evidence to best practice: Effective implementation of change in patients' care. Lancet 362 (2003) 1225-1230